Osimert (Osimertinib) 80mg*30 | Everest Bangladesh Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: Osimert (Osimertinib) 80mg — Bangladesh

Osimert is a Bangladeshi generic of osimertinib, manufactured by Everest Pharmaceuticals Ltd., one of the established oncology-generic makers in Bangladesh. It is supplied as 80 mg film-coated tablets in a 30-tablet pack, matching the originator's standard once-daily strength. Everest is among the Bangladeshi companies that received approval to produce osimertinib generics for the domestic and regional market, and Osimert is one of the well-known brand names in that portfolio.

Bangladesh has a mature generic-pharmaceutical sector, and several of its oncology products are exported across South Asia and beyond. For buyers, Osimert offers a lower-cost osimertinib option whose active ingredient and dose mirror the originator.

What Is Osimert Used For?

Osimert treats EGFR mutation-positive non-small cell lung cancer, including first-line advanced disease, T790M-positive disease after resistance to an earlier EGFR TKI, and adjuvant use after surgery in selected EGFR-mutant patients. Its blood-brain barrier penetration also supports use when brain metastases are present.

How Does Osimert Work?

The active ingredient, osimertinib, is an irreversible inhibitor of mutated EGFR. It blocks the signalling that drives tumour growth in cancers with EGFR exon 19 deletions, L858R mutations and the T790M mutation, while relatively sparing normal EGFR. This selectivity underpins its efficacy and its comparatively manageable side-effect profile.

Indications

  • First-line advanced EGFR-mutant NSCLC.
  • Adjuvant treatment of resected EGFR-mutant NSCLC.
  • T790M-positive NSCLC after prior EGFR-TKI therapy.

Dosage and Administration

Osimert is taken as one 80 mg tablet once daily, with or without food. Tablets should be swallowed whole with water. Doses missed by more than 12 hours are skipped. A 40 mg daily dose may be used for toxicity, and treatment continues until progression or unacceptable side effects.

Side Effects

Common side effects include diarrhoea, rash, dry skin, nail changes, stomatitis and fatigue. Rare but serious events such as interstitial lung disease, QT prolongation and cardiomyopathy require monitoring; patients should report new respiratory symptoms or palpitations promptly.

Storage

Keep Osimert below 30°C, in a dry place, in the original container and away from children. Do not use past the expiry date.

Why Choose the GLT?

GLT sources Bangladeshi generics like Osimert through verified channels and confirms batch and manufacturer details before shipping, which matters for buyers who want an affordable but traceable product. Bangladeshi osimertinib generics typically cost several times less than the branded originator in Western markets, helping patients sustain long-term EGFR-targeted therapy. We support both personal and institutional orders with clear documentation.

How to Order Osimert from GLT

Contact GLT on WhatsApp at +86 15234153837 or email [email protected] to order Osimert 80 mg (30 tablets). Provide the quantity, destination country and order type. We confirm availability, batch documentation and shipping terms before you proceed.

FAQ

Who makes Osimert? Osimert is manufactured by Everest Pharmaceuticals Ltd. in Bangladesh.

Is Osimert a generic of Tagrisso? Yes, Osimert contains the same active ingredient (osimertinib) at the same 80 mg dose as Tagrisso.

Can I buy Osimert online? Yes, GLT supplies Osimert internationally; contact us via WhatsApp or email for availability and shipping.

Related Oncology Products

XinKePing 欣可平 (Avatrombopag) 20mg*10 Tablets | Nanjing Hencer China | GLT

XinKePing — API-plus-tablet integrated avatrombopag from Nanjing Hencer Pharmaceutical (Jemcare group), China Mainland

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

LuciAvat (Avatrombopag) 20mg*28 Tablets | Lucius Pharmaceuticals Laos | GLT

LuciAvat — avatrombopag 20mg (23.6mg maleate) film-coated tablets by Lucius Pharmaceuticals (Lao) Co., Ltd., Vientiane

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker